CELESTICA INC (CLS) Stock Fundamental Analysis

NYSE:CLS • CA15101Q2071

278.985 USD
+4.19 (+1.53%)
Last: Feb 13, 2026, 02:43 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

CLS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 123 industry peers in the Electronic Equipment, Instruments & Components industry. While CLS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CLS is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • CLS had positive earnings in the past year.
  • CLS had a positive operating cash flow in the past year.
  • In the past 5 years CLS has always been profitable.
  • In the past 5 years CLS always reported a positive cash flow from operatings.
CLS Yearly Net Income VS EBIT VS OCF VS FCFCLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • The Return On Assets of CLS (11.54%) is better than 92.68% of its industry peers.
  • CLS has a Return On Equity of 37.56%. This is amongst the best in the industry. CLS outperforms 96.75% of its industry peers.
  • CLS has a Return On Invested Capital of 24.36%. This is amongst the best in the industry. CLS outperforms 99.19% of its industry peers.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLS Yearly ROA, ROE, ROICCLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of CLS (6.72%) is better than 73.98% of its industry peers.
  • In the last couple of years the Profit Margin of CLS has grown nicely.
  • The Operating Margin of CLS (7.80%) is better than 72.36% of its industry peers.
  • CLS's Operating Margin has improved in the last couple of years.
  • CLS's Gross Margin of 12.06% is on the low side compared to the rest of the industry. CLS is outperformed by 75.61% of its industry peers.
  • In the last couple of years the Gross Margin of CLS has grown nicely.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS Yearly Profit, Operating, Gross MarginsCLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLS is creating value.
  • There is no outstanding debt for CLS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLS Yearly Shares OutstandingCLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CLS Yearly Total Debt VS Total AssetsCLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • The Debt to FCF ratio of CLS is 1.69, which is an excellent value as it means it would take CLS, only 1.69 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.69, CLS belongs to the top of the industry, outperforming 80.49% of the companies in the same industry.
  • A Debt/Equity ratio of 0.34 indicates that CLS is not too dependend on debt financing.
  • CLS has a worse Debt to Equity ratio (0.34) than 60.16% of its industry peers.
  • Although CLS does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z N/A
ROIC/WACC2.81
WACC8.66%
CLS Yearly LT Debt VS Equity VS FCFCLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that CLS should not have too much problems paying its short term obligations.
  • CLS has a Current ratio of 1.44. This is in the lower half of the industry: CLS underperforms 74.80% of its industry peers.
  • A Quick Ratio of 0.88 indicates that CLS may have some problems paying its short term obligations.
  • CLS has a worse Quick ratio (0.88) than 84.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS Yearly Current Assets VS Current LiabilitesCLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.59% over the past year.
  • CLS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.67% yearly.
  • The Revenue has grown by 28.46% in the past year. This is a very strong growth!
  • CLS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.61% yearly.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • Based on estimates for the next years, CLS will show a very strong growth in Earnings Per Share. The EPS will grow by 33.06% on average per year.
  • CLS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.15% yearly.
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLS Yearly Revenue VS EstimatesCLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CLS Yearly EPS VS EstimatesCLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 46.04, the valuation of CLS can be described as expensive.
  • CLS's Price/Earnings is on the same level as the industry average.
  • CLS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.67.
  • CLS is valuated quite expensively with a Price/Forward Earnings ratio of 33.22.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CLS is on the same level as its industry peers.
  • CLS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 46.04
Fwd PE 33.22
CLS Price Earnings VS Forward Price EarningsCLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLS is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 70.03
EV/EBITDA 27.84
CLS Per share dataCLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • CLS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CLS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLS's earnings are expected to grow with 33.06% in the coming years.
PEG (NY)1.19
PEG (5Y)1.05
EPS Next 2Y37.93%
EPS Next 3Y33.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CELESTICA INC

NYSE:CLS (2/13/2026, 2:43:04 PM)

278.985

+4.19 (+1.53%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-01
Earnings (Next)04-22
Inst Owners73.66%
Inst Owner Change2.03%
Ins Owners0.59%
Ins Owner Change51.23%
Market Cap32.09B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts81.11
Price Target270.8 (-2.93%)
Short Float %3.49%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.66%
Min EPS beat(2)2.72%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)6.92%
Min EPS beat(4)2.72%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)8.61%
EPS beat(12)12
Avg EPS beat(12)8.72%
EPS beat(16)16
Avg EPS beat(16)8.39%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)1.55%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.11%
Min Revenue beat(4)1.55%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.46%
Revenue beat(12)11
Avg Revenue beat(12)3.05%
Revenue beat(16)15
Avg Revenue beat(16)3.51%
PT rev (1m)8.55%
PT rev (3m)39.81%
EPS NQ rev (1m)10.84%
EPS NQ rev (3m)11.62%
EPS NY rev (1m)0%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)9.38%
Revenue NQ rev (3m)11.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.61%
Valuation
Industry RankSector Rank
PE 46.04
Fwd PE 33.22
P/S 2.59
P/FCF 70.03
P/OCF 48.66
P/B 14.48
P/tB 19.85
EV/EBITDA 27.84
EPS(TTM)6.06
EY2.17%
EPS(NY)8.4
Fwd EY3.01%
FCF(TTM)3.98
FCFY1.43%
OCF(TTM)5.73
OCFY2.05%
SpS107.71
BVpS19.27
TBVpS14.06
PEG (NY)1.19
PEG (5Y)1.05
Graham Number51.25
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z N/A
F-Score7
WACC8.66%
ROIC/WACC2.81
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y38.59%
EPS Next 2Y37.93%
EPS Next 3Y33.06%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year32.94%
Revenue Next 2Y32.93%
Revenue Next 3Y28.15%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year55.75%
EBIT Next 3Y35.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 6 / 10 to CLS.


What is the valuation status of CELESTICA INC (CLS) stock?

ChartMill assigns a valuation rating of 4 / 10 to CELESTICA INC (CLS). This can be considered as Fairly Valued.


What is the profitability of CLS stock?

CELESTICA INC (CLS) has a profitability rating of 7 / 10.


What is the valuation of CELESTICA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELESTICA INC (CLS) is 46.04 and the Price/Book (PB) ratio is 14.48.


How financially healthy is CELESTICA INC?

The financial health rating of CELESTICA INC (CLS) is 4 / 10.